ABSTRACT. The purpose of this study was to identify differentially expressed (DE) genes and biological processes associated with changes in gene expression in ankylosing spondylitis (AS). We performed a metaanalysis using the integrative meta-analysis of expression data program on publicly available microarray AS Gene Expression Omnibus (GEO) datasets. We performed Gene Ontology (GO) enrichment analyses and pathway analysis using the Kyoto Encyclopedia of Genes and Genomes. Four GEO datasets, including 31 patients with AS and 39 controls, were available for the meta-analysis. We identified 65 genes across the studies that were consistently DE in patients with AS vs controls (23 upregulated and 42 downregulated). The upregulated gene with the largest effect size (ES; -1.2628, P = 0.020951) was integral membrane protein 2A (ITM2A), which is expressed by CD4+ T cells and plays a role in activation of T cells. The downregulated gene with the largest ES (1.2299, P = 0.040075) was mitochondrial ribosomal protein S11 (MRPS11). The most significant GO enrichment was in the respiratory electron transport chain category (P = 1.67 x 10 -9
INTRODUCTION
Ankylosing spondylitis (AS) is a chronic inflammatory disorder characterized by inflammation in the spine and sacroiliac joints resulting in initial bone and joint erosion and subsequent ankylosis (Brown et al., 2002) . Human leukocyte antigen (HLA) B27 was the first genetic factor to be associated with AS, and it confers considerable susceptibility to the disease. However, there has been increasing evidence to suggest that non-HLA-B27 genes also contribute to AS pathogenesis (Lee et al., 2005a) . Strong genetic factors have been implicated in the etiology of AS, but the biological mechanisms associated with the disease are still unclear.
High-throughput genomics technologies such as microarrays have improved our understanding of complex gene interactions and networks during disease development. Microarrays measure the expression of thousands of genes simultaneously on a genome-wide scale (Golub et al., 1999) . Alterations in genetic profiles can be correlated to altered gene functions and biochemical activities. Microarray technology is a powerful tool that has become one of the most frequently used investigational methods in medical research.
Identification of gene expression signatures that differentiate disease states from those of healthy controls are dependent on sample availability, sample size, and heterogeneous datasets (Ramasamy et al., 2008) . Although many microarray studies have produced lists of differentially expressed (DE) genes, there tend to be inconsistencies between studies due to the limitations of small sample sizes and variable results (Siddiqui et al., 2006) .
To address these challenges, meta-analysis can be performed using publically available data from genome-wide gene expression studies in specific diseases Rung and Brazma, 2013) . Meta-analysis can enhance the reliability and generalizability of studies to obtain a more precise estimate of gene expression profiles . Meta-analysis enhances the statistical power for identifying more robust and reliable gene signatures (Lee and Nath, 2005; Lee et al., 2005b; Choi et al., 2006) . Recently, a new user-friendly microarray meta-analysis tool called integrative meta-analysis of expression data (INMEX) has been developed to support the meta-analysis of multiple gene expression datasets, as well as to enable the integration of datasets of gene expression and pathways (Xia et al., 2013) .
In order to overcome the limitations of individual studies, resolve inconsistencies, and reduce the likelihood of false-positive or -negative associations caused by random errors, we performed a microarray meta-analysis with the objective to identify DE genes in AS and biological processes associated with these gene expression changes.
MATERIAL AND METHODS

Identification of eligible AS gene expression datasets
A search for microarray datasets that examined DE genes between patients with AS and controls was conducted. We utilized the NCBI Gene Expression Omnibus (GEO) database (http://www.ncbi.nlm.nih.gov/geo/) to identify microarray datasets submitted through September, 2013 (Barrett et al., 2011) . The key word "ankylosing spondylitis" was used in the search. Studies were included in the analysis if they met the following criteria: 1) case-control studies; 2) included gene expression data; and 3) included patients diagnosed with AS based on specific AS diagnostic criteria (van der Linden et al., 1984) . We excluded animal studies and studies in which microarray data could not be obtained. The following information was extracted from each identified study: GEO accession number, sample type, platform, number of cases and controls, references, and gene expression data.
Meta-analysis of microarray datasets
All available AS microarray datasets were downloaded from the NCBI GEO database. We constructed data tables containing gene expression values or relative expression values with genes/probes in rows and samples/experiments delineated in individual columns. After uploading the datasets into the INMEX program (http://inmex.ca/INMEX) (Xia et al., 2013) , we annotated the data by converting different gene or probe IDs to Entrez IDs. For each probe set, intensity values were log-transformed and normalized to zero mean and unit variance (Bolstad et al., 2003) . When all datasets were uploaded, processed, and annotated, we performed a data integrity check before proceeding to the meta-analysis stage. The random-effects model, which assumes that individual studies contain substantial diversity and assesses both withinstudy sampling error and between-study variance (DerSimonian and Laird, 1986; Choi et al., 2003) , is used in the presence of significant between-study heterogeneity (DerSimonian and Laird, 1986) . Statistical manipulations were undertaken using INMEX.
Functional analysis
To further understand the functions of the genes present in the data lists, we performed GO enrichment analysis using hypergeometric tests (http://www.geneontology.org/) (Falcon and Gentleman, 2007) . To functionally annotate the genes in the list, we identified over-represented Kyoto Encyclopedia of Genes and Genomes (KEGG) categories (http://www.genome. ad.jp/) (Hua et al., 2010) . Functional analysis was undertaken using INMEX.
RESULTS
Studies included in the meta-analysis
Eighty-five studies were identified by electronic search, eight of which were selected for full dataset review based on title and abstract details. Four datasets were excluded because they contained no data for meta-analysis, and four microarray datasets met our inclusion criteria (Table 1) . These datasets consisted of results from two synovium and two blood sample studies, and included a total of 31 patients with AS and 39 controls. Selected details of the individual studies are summarized in Table 1 . Heat maps using differential expression analysis of individual datasets were used to visualize a subset of genes across the four studies ( Figure 1 ). 
Meta-analysis of gene expression in AS
We used a random-effects model of effect size (ES) measurements to integrate gene expression patterns and incorporate between-study heterogeneities because the estimated Q value was not in a chi-squared distribution. We selected the DE genes with a P value < 0.05. There were 51 "gained" genes and 521 "lost" genes in this meta-analysis ( Figure 2 ). "Gained" genes are the DE genes uniquely identified in the meta-analysis (Xia et al., 2013) . These genes showed relatively weak but consistent expression profiles across the individual datasets. Their detection benefits from a larger number of samples and therefore they have more confidence to be declared as DE genes. "Lost" genes were those identified as DE genes in any individual analysis, but not in the meta-analysis. These genes either show conflicting changes in expression profiles between studies, or very large variation across different studies (arising from i.e. batch effect or system bias due to different platforms).
Identification of DE genes in AS
We identified a total of 65 genes across the four studies that were consistently DE in AS. Among the 65 DE genes, 23 were upregulated and 42 were downregulated. A list of the top 20 most significantly up-or downregulated genes is presented in Tables 2 and 3. The upregulated gene with the largest ES (-1.2628) was integral membrane protein 2A (ITM2A), which is expressed by CD4+ T cells and plays a role in activation of T cells (Kirchner and Bevan, 1999) . The upregulated gene with the lowest P value (0.005673) was transforming growth factor beta receptor III (TGFBR3), which, as part of the TGF pathway, is a true bone mineral density-associated gene (Xiong et al., 2009 ). These genes have not been previously reported to be associated with AS. Many consistently DE genes from the datasets are involved in immune dysregulation ( Table 2 ). The downregulated gene with the largest ES (1.2299) was mitochondrial ribosomal protein S11 (MRPS11), which plays a role in protein synthesis within the mitochondrion (Emdadul Haque et al., 2008) . The downregulated gene with the lowest P value (0.005673) was homogentisate 1,2-dioxygenase (HGD), which is involved in the catabolism of the amino acids tyrosine and phenylalanine (Zatkova et al., 2012) . HGD deficiency is associated with bone deformity in AS (Balaban et al., 2006) . Further studies are needed to elucidate the function of these DE genes in the pathogenesis of AS (Table 3 ). 
Functional analysis
To identify the biological processes associated with gene expression changes in AS, we performed GO analysis on the DE genes. We identified 210 significant enrichments in the DE genes, which were classified into 10 GO categories (Figure 3) . The most significant enrichment was in the GO category respiratory electron transport chain (P = 1.67 x 10 -9
). Other significant GO categories included cellular respiration (P = 1.70 x 10 -9 ) and the electron transport chain (P = 2.37 x 10 -8 ) ( Table 4 ). The identified GO terms further divided into a small number of categories: biological regulation, cellular metabolic process, small molecule metabolic process, cellular component organization, generation of precursor metabolites and energy, energy derivation by oxidation of organic compounds, oxidation-reduction process, cellular respiration, respiratory electron transport chain, electron transport chain, and others ( Figure 3 ). To further investigate the functions of the 65 DE genes, we mapped them to the KEGG database (Table 5) . We identified 42 significant pathways based on the KEGG database analysis, the most significant of which was transcriptional misregulation in cancer (P = 0.0025629). Other significant pathways included circadian rhythm -mammal (P = 0.0034372) and fat digestion and absorption (P = 0.035981; Table 5 ).
DISCUSSION
Many genes are DE in inflammatory diseases such as AS (Pimentel-Santos et al., 2011) , and the challenge is to identify the most important genes and pathways associated with a particular disease. These in turn will aid in the development of treatments and therapies for the disorder. Therefore, characterization of the molecular and cellular events that occur during the pathogenesis of AS is an important endeavor. To do this, we chose a meta-analysis approach that combined DE genes from multiple microarray datasets to identify genes that were consistently DE and that reached statistical significance, and performed GO enrichment analysis using hypergeometric tests and pathway analysis using KEGG (Xia et al., 2013 We performed a meta-analysis using four publicly available GEO datasets to identify common biological mechanisms involved in the pathogenesis of AS. We identified genes that were consistently over-or under-expressed, significant GO enrichments, and pathways associated with AS. In total, 65 genes across the four studies were consistently DE in AS (23 up-and 42 downregulated). The upregulated gene with the lowest P value (0.005673) was TGFBR3 and the upregulated gene with the largest ES (-1.2628) was ITM2A. Although the roles and association of these genes with AS have not yet been reported, ITM2A is involved in osteoand chondrogenic cellular differentiation (cells responsible for the development of bone and cartilage, respectively) (Deleersnijder et al., 1996) . ITM2A is also involved in the activation of T cells in the immune system (Kirchner and Bevan, 1999) and in myocyte differentiation (Van den Plas and Merregaert, 2004) . Furthermore, some of the upregulated genes, e.g., ITM2A and collagen, type IX, alpha 2 (COL9A2), might modulate cartilage and bone metabolism leading to AS progression. Our meta-analysis of gene expression data also revealed upregulation of chemokine C-X3-C motif receptor 1 (CX3CR1), consistent with previous microarray results of proinflammatory profiles in AS (Pimentel-Santos et al., 2011) . Additional specific upregulated genes are involved in mediation of inflammation and in the chemotaxis pathway. The downregulated gene with the lowest P value (0.005673) was HGD, which is involved in the catabolism of the amino acids tyrosine and phenylalanine. HGD deficiency is relevant to the bone deformity of AS, as patients with HGD deficiency experience progressive kyphosis, obliteration of intervertebral spaces, and marginal intervertebral osteophytes resembling the syndesmophytes in AS (Zatkova et al., 2012) .
The most significant GO enrichment amongst the list of 210 categories was the respiratory electron transport chain (P = 1.67 x 10 -9
). Other significant GO categories included cellular respiration (P = 1.70 x 10 -9
) and the electron transport chain (P = 2.37 x 10 -8 ). Complexes I and II of the electron transport chain release reactive oxygen species (ROS) exclusively in the mitochondrial matrix, whereas complex III generates ROS on both sides of the mitochondrial inner membrane (Sena and Chandel, 2012) . ROS can damage DNA, RNA, and proteins, and play a key role in the pathogenesis of inflammatory diseases like AS (Özenirler et al., 2013) . Amongst the 42 pathways in our KEGG analysis, transcriptional misregulation in cancer, circadian rhythm, and fat digestion and absorption were the most differently regulated in AS. Transcriptional misregulation is known to contribute to tumorigenesis, and overexpressed oncogenic transcription factors alter the autoregulatory circuitry of the cell (Lee and Young, 2013) . Thus, transcriptional misregulation can contribute to cancer, autoimmunity, and inflammation (Lee and Young, 2013) . The GO categories and KEGG pathways identified in this study merit further study and validation. The present study has some limitations that require consideration. First, heterogeneity and confounding factors may have distorted the analysis. Clinical samples might have been heterogeneous with respect to clinical activity, severity, or gender. Second, the inflammatory nature of AS results in changes in gene expression in the white blood cell population and in the synovium. There are differences in gene expression between the synovium and blood that were not considered. However, our meta-analysis integrated samples from different tissues, which might have enabled us to detect genes that we would otherwise have missed in subgroup analysis. Third, the numbers of studies and samples included in this meta-analysis were small. Small sample size and study number may not result in enough power to detect true gene expression changes involved in the pathogenesis of AS. Fourth, the magnitudes of the changes in gene expression identified were not large.
In conclusion, meta-analysis of gene expression profiling provided a global overview of differential gene expression in AS identifying 65 DE genes (23 up-and 42 downregulated genes). Integrated pathway analysis of the differentially regulated genes indicated roles in electron transport, inflammation, and various other processes. Our meta-analysis revealed previously unknown transcriptional changes in AS. Identification of the gene expression changes observed in AS will provide valuable insights into the pathogenesis of AS. Further functional studies might provide additional insights into the role of the differentially regulated genes in the pathophysiology of AS.
